BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11236945)

  • 1. Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience.
    Campana D; Neale GA; Coustan-Smith E; Pui CH
    Leukemia; 2001 Feb; 15(2):278-9. PubMed ID: 11236945
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
    Gaipa G; Basso G; Biondi A; Campana D
    Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical scheme of minimal residual disease detection with Ig/TCR rearrangements as molecular targets in childhood acute lymphoblastic leukemia].
    Li ZG; Cui L; Gao C
    Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):165-9. PubMed ID: 21575362
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
    Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL.
    Szczepański T; van der Velden VH; Raff T; Jacobs DC; van Wering ER; Brüggemann M; Kneba M; van Dongen JJ
    Leukemia; 2003 Nov; 17(11):2149-56. PubMed ID: 14576730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).
    Shahkarami S; Mehrasa R; Younesian S; Yaghmaie M; Chahardouli B; Vaezi M; Rezaei N; Nikbakht M; Alimoghaddam K; Ghavamzadeh A; Tavakkoly-Bazzaz J; Ghaffari SH
    Ann Hematol; 2018 Apr; 97(4):585-595. PubMed ID: 29392424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of clonotypic Ig and T-cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease.
    Peham M; Panzer S; Fasching K; Haas OA; Fischer S; Marschalek R; Gadner H; Panzer-Grümayer ER
    Br J Haematol; 2002 May; 117(2):315-21. PubMed ID: 11972513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal residual disease in acute leukemia.
    van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
    J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring.
    van der Velden VH; Wijkhuijs JM; van Dongen JJ
    Leukemia; 2008 Mar; 22(3):641-4. PubMed ID: 17851557
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.
    Kreyenberg H; Eckert C; Yarkin Y; Reising M; Willasch A; Handgretinger R; Kremens B; von Stackelberg A; Henze G; Klingebiel T; Bader P
    Leukemia; 2009 Jul; 23(7):1355-8. PubMed ID: 19357703
    [No Abstract]   [Full Text] [Related]  

  • 13. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
    Guidal C; Vilmer E; Grandchamp B; Cavé H
    Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia.
    van der Velden VH; Joosten SA; Willemse MJ; van Wering ER; Lankester AW; van Dongen JJ; Hoogerbrugge PM
    Leukemia; 2001 Sep; 15(9):1485-7. PubMed ID: 11516112
    [No Abstract]   [Full Text] [Related]  

  • 15. Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease.
    Nakao M; Janssen JW; Erz D; Seriu T; Bartram CR
    Leukemia; 2000 Mar; 14(3):522-4. PubMed ID: 10720156
    [No Abstract]   [Full Text] [Related]  

  • 16. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
    Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
    Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
    van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
    Recent Results Cancer Res; 1993; 131():157-84. PubMed ID: 8210636
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
    Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
    Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
    Szczepański T; Beishuizen A; Pongers-Willemse MJ; Hählen K; Van Wering ER; Wijkhuijs AJ; Tibbe GJ; De Bruijn MA; Van Dongen JJ
    Leukemia; 1999 Feb; 13(2):196-205. PubMed ID: 10025893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minimal residual disease in childhood acute leukemias].
    Pawińska K; Balwierz W; Baran J
    Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.